Skip to main content
  • Saved

made a Post

YKL-40 as a novel biomarker in cardio-metabolic disorders and inflammatory diseases - PubMed

YKL-40 as a novel biomarker in cardio-metabolic disorders and inflammatory diseases - PubMed

Source :

https://pubmed.ncbi.nlm.nih.gov/33002471/

Dyslipidaemia is associated with numerous health problems that include the combination of insulin resistance, hypertension and obesity, ie, metabolic syndrome. Although the use of statins to decrease serum low density lipoprotein cholesterol (LDL-C) has been an effective therapeutic in treating athe ...